Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Neo

Bryan Caplan on NIMBYism and Economic Ignorance

Leading expert on political ignorance and housing comments on evidence indicating that ignorance, not self-interest, is at the root of most opposition to zoning reform.

Reason

3D X-DRAM Roadmap: 1Tb Die Density by 2030

3D X-DRAM from NEO Semiconductor uses technology inspired by 3D NAND. The firm's roadmap sees the arrival of 1Tb DRAM dies by 2030.

Tom’s Hardware

The Parent Company Q3 Revenue Drops 28% Sequentially, CEO Says New Products Coming Soon

The Parent Company (NEO: GRAM.U) (OTCQX: GRAMF) announced its financial results on Monday for the quarter ended September 30, 2022 ("Q3 2022"). “All amounts are expressed in U.S. dollars,” reads a press release.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

If You Invested $1,000 In These 3 Crypto Tokens You Would Have This Much In Crypto Dividends

When navigating the cryptocurrency market it can be difficult to distinguish between the “s— tokens” and tokens that actually provide value through a utility.

Benzinga

Satellite images show North Korea may be building deadly new ballistic missile submarine

North Korea could be planning to launch a new submarine capable of firing ballistic missiles, says think tank 38 North, citing satellite images showing a submarine construction quay

Daily Mirror

1 Stock to Buy This Week and 1 Stock to Dump

Investors’ sentiment is significantly mixed at the moment, with market volatility at its peak. It could be wise to buy quality stock Vertex Pharmaceuticals (VRTX), which possesses robust financials. However, fundamentally weak stock NeoGenomics (NEO) is best avoided now. Read on….

StockNews.com

4 Stocks That Just Went From Bad To Worse

Stagflation is the word of the hour, with reckless inflation and aggressive interest rate hikes leading to slashed growth estimates. Our proprietary rating system recently downgraded MicroStrategy (MSTR), NeoGenomics (NEO), SolarEdge (SEDG), and Block (SQ) from Sell to Strong Sell. So, these stocks are best avoided now. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Stocks That Just Went From Bad To Worse

Surging inflation and the Fed’s continued interest rate hikes have kept equities under pressure lately, driving the S&P 500 index into bearish territory. Given this backdrop, fundamentally weak stocks Boxed (BOXD), KalVista Pharmaceuticals (KALV), and NeoGenomics (NEO) are best avoided now. These stocks were downgraded from ‘Sell’ to ‘Strong Sell’…

StockNews.com

MindMed Appoints Schond L. Greenway As CFO

Mind Medicine Inc. (NASDAQ: MNMD), (NEO:MMED), a clinical stage bio-pharmaceutical company developing novel products to treat brain health disorders, appointed Schond L. Greenway as CFO.

Benzinga

TILT Holdings Q1 Revenue Down 22% Sequentially To $42.4M, $55 Million In Leaseback Transaction

TILT Holdings Inc. (NEO: NEO) (OTCQX: TLLTF) reported its financial and operating results for the three months ended March 31, 2022.

Benzinga

Why Neo Performance Materials Shares Are Surging Today

Neo Performance Materials Inc (TSX:NEO) (OTC:NOPMF) reported first-quarter revenue growth of 27.1% year-over-year to $166.28 million. Adjusted EPS improved to $0.56 from $0.39 in 1Q21. Volumes saw a decline of 16.6% Y/Y, reflecting the recent spike in COVID-19 in Asia, several natural disasters that impacted production facilities and customers, and the ongoing…

Benzinga

Trees Secures Funding For Acquisition Of Camp Cannabis Retail Stores In Ontario, Closes Private Placement Of Shares

Trees Corporation (NEO: TREE) has closed a non-brokered private placement of its 34.17 million at $0.03 per unit for gross proceeds of approximately $1.03 million. Under the private placement, each unit is comprised of one common share and one-half of one common share purchase warrant of the company.

Benzinga

Analyst Ratings for NeoGenomics

Analysts have provided the following ratings for NeoGenomics (NASDAQ:NEO) within the last quarter:

Benzinga

The Mix: Cool things to do in Chicago April 28-May 4

“Lookingglass Alice,” the One of a Kind spring show, and “Jersey Boys” are among the entertainment highlights in the week ahead.

Chicago Sun-Times

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

NeoGenomics: Q1 Earnings Insights

NeoGenomics (NASDAQ:NEO) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Bangkok Post

Hopes high for QSNCC as Apec summit approaches

N.C.C. Management & Development expects the 2022 Apec summit in Thailand to draw at least 30,000 visitors to the new Queen Sirikit National Convention Center (QSNCC).

Benzinga

Dash, Stacks Among Top Crypto Movers In 24H

According to Benzinga Pro, the following are the crypto gainers and losers at the time of publication:

Benzinga

Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide

U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space

The psychedelics legislative landscape continues to move forward with Hazel Park, Michigan enacting decriminalization measures for naturally-produced psychedelic molecules, becoming the third city in the state to do so after Ann Arbor and Detroit. In Utah, Governor Cox signed a psychedelics research bill into law and positive legislation around psilocybin is continuing…

Benzinga

Why NeoGenomics Stock Is Plunging Today

NeoGenomics Inc's (NASDAQ:NEO) CEO Mark Mallon will step down as CEO and member of the Board, effective immediately. The Board has retained Russell Reynolds to search for the Company's next CEO The Board has appointed current Chair Lynn Tetrault, Esq. as Executive Chair and established an Interim Office of the CEO. Read…

Benzinga

10 Biggest Price Target Changes For Tuesday

BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.

Benzinga

Where NeoGenomics Stands With Analysts

Over the past 3 months, 8 analysts have published their opinion on NeoGenomics (NASDAQ:NEO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

MindMed Reports Full Year 2021 Financial Results, Announces Changes In Leadership

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (NEO: MMED) reported its financial results for the full year ended December 31, 2021. 2021 Financial Results Cash balance as of December 31, 2021, was $133.5 million compared to $80.1 million as of December 31, 2020. Net cash in operating activities was $45.8 million for…

Benzinga

EXCLUSIVE: Here's Why Investments In WonderFi Are 'A Global Play'

Earlier this year, WonderFi Technologies Inc (NEO: WNDR) announced its intention to acquire First Ledger Corporation, the parent of Bitbuy, the first approved crypto marketpl

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.